Organ dysfunction following stem cell transplantation: relationship to plasma cytokine concentrations

Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation [see comments]

1990 • 591 citations

Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings.

1997 • 484 citations

Pathophysiologic mechanisms of acute graft-vs.-host disease

1999 • 348 citations

Tissue factor expression by endothelial cells in sickle cell anemia.

1998 • 225 citations

High busulfan concentrations are associated with increased transplant-related mortality in allogeneic bone marrow transplant patients

1997 • 117 citations

Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome

2000 • 110 citations

High spontaneous IL-10 production in unrelated bone marrow transplant recipients is associated with fewer transplant-related complications and early deaths

1999 • 81 citations

Phospholipase A2 activation and autoinduction of tumor necrosis factor gene expression by tumor necrosis factor.

1990 • 73 citations

Multiple Organ Dysfunction Syndrome in Bone Marrow Transplantation

1995 • 60 citations

MEDIATORS AND MECHANISMS OF ACUTE LUNG INJURY

2000 • 38 citations

Increased platelet transfusion requirement is associated with multiple organ dysfunctions in patients undergoing hematopoietic stem cell transplantation

1998 • 30 citations

Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for marrow transplantation: Risk factors for early regimen-related toxicity

1994 • 28 citations

Central nervous system dysfunction as the first manifestation of multiple organ dysfunction syndrome in stem cell transplant patients

2000 • 23 citations

Pilot Trial of Cytoprotection With Amifostine Given With High-Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation

2000 • 22 citations

A prospective randomized double-blind trial of antithrombin III concentrate in the treatment of multiple-organ dysfunction syndrome during hematopoietic stem cell transplantation

1998 • 22 citations

A prospective randomized double-blind trial of antithrombin III concentrate in the treatment of multiple-organ dysfunction syndrome during hematopoietic stem cell transplantation

1998 • 16 citations

The Multiple Organ Dysfunction Syndrome in Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation

1999 • 13 citations